Insider Trading History of Chang Michael N

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Chang Michael N since 2007. The trader's CIK number is 1380901. At the time of the last reporting, Chang Michael N was the CEO and President of Optimer Pharmaceuticals Inc. (stock ticker symbol OPTR). Also see all insider trading activities at Optimer Pharmaceuticals Inc.


Yearly summary of insider trading at Optimer Pharmaceuticals Inc (OPTR) by Chang Michael N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 OPTR 0 $0 0 $0 647,315 $5,554,330
2011 OPTR 0 $0 0 $0 100,000 $108,300
2010 OPTR 0 $0 0 $0 157,286 $177,864
2009 OPTR 33,000 $367,625 0 $0 51,538 $22,315
2008 OPTR 9,542 $62,410 0 $0 0 $0
2007 OPTR 166,965 $1,251,754 0 $0 0 $0


Insider trading of Optimer Pharmaceuticals Inc (OPTR) by Chang Michael N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-09-04 OPTR Option Ex 281,615 8.39 2,361,623
2013-04-23 OPTR Option Ex 117,263 1.08 126,995
2013-04-09 OPTR Option Ex 103,125 12.34 1,272,562
2013-04-03 OPTR Option Ex 145,312 12.34 1,793,150
2011-04-25 OPTR Option Ex 100,000 1.08 108,300
2010-06-01 OPTR Option Ex 6,922 2.17 15,020
2010-01-04 OPTR Option Ex 150,364 1.08 162,844
2009-12-28 OPTR Buy 10,000 10.85 108,500
2009-12-29 OPTR Buy 8,000 10.80 86,400
2009-11-25 OPTR Buy 15,000 11.52 172,725
2009-01-07 OPTR Option Ex 51,538 .43 22,315
2008-06-13 OPTR Buy 5,000 7.00 35,000
2008-05-15 OPTR Buy 4,542 6.04 27,410
2007-11-15 OPTR Buy 2,000 5.95 11,900
2007-08-09 OPTR Buy 30,000 8.20 245,999
2007-08-06 OPTR Buy 10,000 9.05 90,500
2007-07-16 OPTR Buy 10,000 9.86 98,600
2007-02-14 OPTR Buy 114,965 7.00 804,755

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chang Michael N (CEO and President of Optimer Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.